Development and validation of a set of patient reported outcome measures to assess effectiveness of asthma prophylaxis.


Journal

BMC pulmonary medicine
ISSN: 1471-2466
Titre abrégé: BMC Pulm Med
Pays: England
ID NLM: 100968563

Informations de publication

Date de publication:
17 Sep 2021
Historique:
received: 07 02 2021
accepted: 09 09 2021
entrez: 18 9 2021
pubmed: 19 9 2021
medline: 4 1 2022
Statut: epublish

Résumé

In the local setting, asthma control is assessed by symptoms and signs elicited by clinicians because of the limited availability of spirometry. Hence, we intended to develop a patient reported outcome measure (PROM) with more holistic interpretation that could also serve as a tool to measure the asthma control in resource limited settings. Therefore, this study was carried out in Northern Sri Lanka to develop and validate the Asthma Control PROM (AC-PROM) Tamil to measure the effectiveness of asthma prophylaxis based on symptoms, exacerbation and limitation of activity which could also serve as an easy measure of asthma control to the provider. The AC-PROM Tamil was developed in 3 steps: item generation, item reduction and psychometric evaluation. Items were generated through thematic analysis from focus group discussions among patients with asthma. Items were converted to an interviewer administered questionnaire in Tamil in the format of 5-point Likert scale. Item reduction was done by two rounds of online Delphi surveys among 10 experts and an exploratory factor analysis among 200 patients with asthma. The face and content validity were assessed by a panel of experts during Delphi survey and patients during the pre-test of the tool. Criterion validity of the tool was assessed against the forced expiratory volume in one second of 187 patients with asthma. The cut-off value to assess the asthma control was determined by receiver operating characteristic curve. Reliability was verified by Cronbach's alpha coefficient. From thematic analysis of focus group discussions 10 items were generated. One item was removed during Delphi survey. Exploratory factor analysis indicated removal of another item with 8 items categorised into two factors. Cronbach's alpha coefficient of factors 1 and 2 were 0.821 and 0.903 respectively, indicating good reliability. Observations made by experts and responses made by patients were incorporated to improve the clarity and relevance of the items. Criterion validity was demonstrated by significant correlation between the AC-PROM Tamil and forced expiratory volume in one second (r = 0.66, p = 0.001). The cut-off value of the AC-PROM Tamil to detect asthma control was 28.5 with 79% (95% CI 71.3-86.9) sensitivity and 71% (95% CI 61.9-79.6) specificity. The AC-PROM Tamil showed moderate accuracy (the area under the receiver operating characteristic curve = 0.796; 95% CI 0.73-0.86). Response rate of the AC-PROM Tamil was 100% and time taken to complete was 3-4 min. The AC-PROM Tamil is a simple, feasible and reasonably accurate tool to assesses the effectiveness of asthma prophylaxis, particularly in resource limited settings.

Sections du résumé

BACKGROUND BACKGROUND
In the local setting, asthma control is assessed by symptoms and signs elicited by clinicians because of the limited availability of spirometry. Hence, we intended to develop a patient reported outcome measure (PROM) with more holistic interpretation that could also serve as a tool to measure the asthma control in resource limited settings. Therefore, this study was carried out in Northern Sri Lanka to develop and validate the Asthma Control PROM (AC-PROM) Tamil to measure the effectiveness of asthma prophylaxis based on symptoms, exacerbation and limitation of activity which could also serve as an easy measure of asthma control to the provider.
METHODS METHODS
The AC-PROM Tamil was developed in 3 steps: item generation, item reduction and psychometric evaluation. Items were generated through thematic analysis from focus group discussions among patients with asthma. Items were converted to an interviewer administered questionnaire in Tamil in the format of 5-point Likert scale. Item reduction was done by two rounds of online Delphi surveys among 10 experts and an exploratory factor analysis among 200 patients with asthma. The face and content validity were assessed by a panel of experts during Delphi survey and patients during the pre-test of the tool. Criterion validity of the tool was assessed against the forced expiratory volume in one second of 187 patients with asthma. The cut-off value to assess the asthma control was determined by receiver operating characteristic curve. Reliability was verified by Cronbach's alpha coefficient.
RESULTS RESULTS
From thematic analysis of focus group discussions 10 items were generated. One item was removed during Delphi survey. Exploratory factor analysis indicated removal of another item with 8 items categorised into two factors. Cronbach's alpha coefficient of factors 1 and 2 were 0.821 and 0.903 respectively, indicating good reliability. Observations made by experts and responses made by patients were incorporated to improve the clarity and relevance of the items. Criterion validity was demonstrated by significant correlation between the AC-PROM Tamil and forced expiratory volume in one second (r = 0.66, p = 0.001). The cut-off value of the AC-PROM Tamil to detect asthma control was 28.5 with 79% (95% CI 71.3-86.9) sensitivity and 71% (95% CI 61.9-79.6) specificity. The AC-PROM Tamil showed moderate accuracy (the area under the receiver operating characteristic curve = 0.796; 95% CI 0.73-0.86). Response rate of the AC-PROM Tamil was 100% and time taken to complete was 3-4 min.
CONCLUSION CONCLUSIONS
The AC-PROM Tamil is a simple, feasible and reasonably accurate tool to assesses the effectiveness of asthma prophylaxis, particularly in resource limited settings.

Identifiants

pubmed: 34535111
doi: 10.1186/s12890-021-01665-6
pii: 10.1186/s12890-021-01665-6
pmc: PMC8449463
doi:

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

295

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

© 2021. The Author(s).

Références

J Allergy Clin Immunol. 2004 Jan;113(1):59-65
pubmed: 14713908
Control Clin Trials. 2004 Dec;25(6):535-52
pubmed: 15588741
Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 1):1647-52
pubmed: 10556135
Eur Respir J. 1999 Oct;14(4):902-7
pubmed: 10573240
Patient. 2012;5(2):79-87
pubmed: 22428752
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882
Acad Emerg Med. 1996 Sep;3(9):895-900
pubmed: 8870764
Respir Med. 2004 Oct;98 Suppl B:S9-15
pubmed: 15481283
J Aging Health. 2012 Mar;24(2):323-44
pubmed: 21956096
BMC Med Res Methodol. 2011 Mar 11;11:26
pubmed: 21396104
J Allergy Clin Immunol. 2007 Dec;120(6):1368-72
pubmed: 17981316
PLoS One. 2015 Sep 01;10(9):e0134125
pubmed: 26327606
Health Qual Life Outcomes. 2006 Oct 11;4:79
pubmed: 17034633
Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70-e88
pubmed: 31613151
Br J Gen Pract. 2014 Aug;64(625):e509-15
pubmed: 25071064
NPJ Prim Care Respir Med. 2014 Jun 26;24:14020
pubmed: 24964767

Auteurs

Yalini Guruparan (Y)

Department of Pharmacology, Faculty of Medicine, University of Jaffna, Jaffna, Sri Lanka. yalinig@univ.jfn.ac.lk.

Thiyahiny S Navaratinaraja (TS)

Department of Pharmacology, Faculty of Medicine, University of Jaffna, Jaffna, Sri Lanka.

Gowry Selvaratnam (G)

Department of Medicine, Faculty of Medicine, University of Jaffna, Jaffna, Sri Lanka.

Nalika Gunawardena (N)

World Health Organization, Country Office, Colombo, Sri Lanka.

Shalini Sri Ranganathan (S)

Department of Pharmacology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH